Gilead Sciences (GILD)
(Delayed Data from NSDQ)
$113.18 USD
+0.89 (0.79%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $113.18 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
B Value A Growth B Momentum A VGM
Fundamental Charts
About Dividend Yield (TTM)
For Gilead Sciences, Inc., the company has a dividend yield of 2.81% compared to the Medical - Biomedical and Genetics industry's median yield of zero percent.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
GILD 113.18 +0.89(0.79%)
Will GILD be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for GILD based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for GILD
Gilead Sciences (GILD) Expected to Beat Earnings Estimates: Should You Buy?
Is Most-Watched Stock Gilead Sciences, Inc. (GILD) Worth Betting on Now?
GILD: What are Zacks experts saying now?
Zacks Private Portfolio Services
Gilead Sciences (GILD) Stock Dips While Market Gains: Key Facts
Top Research Reports for NVIDIA, Netflix & Goldman Sachs
Here's Why Gilead Sciences (GILD) is a Strong Value Stock
Other News for GILD
Earnings Scorecard: 18 out of 21 healthcare firms beat earnings forecast this week
Notable healthcare headlines for the week: Trump’s ultimatum to big pharma, Novo Nordisk, UnitedHealth and Moderna in focus
Earnings week ahead: AMD, PLTR, PFE, DIS, O, ET, SHOP, GILD, MCD, CAT, VTRS, BP, UBER, CGC, and more
ClearBridge Value Portfolios Q2 2025 Commentary
Market Voices: Trump vs. Big Pharma, Swiss tariffs, tariff legality